课题基金 / 基金详情

Non-invasive imaging of T cells

Non-invasive imaging of T cells
T 细胞的非侵入性成像
批准号:
10015276
负责人:
Changning Wang
金额:
$8.3万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2022-06-30
关键词:
ActinsAdaptor Signaling ProteinAlzheimer&aposs DiseaseAnimalsAntigensAsthmaAutoimmune ProcessBindingBiological AssayBody Weight decreasedBrainBrain NeoplasmsBrain imagingC-terminalCarbonCell SurvivalCell physiologyCellsCladribineComplexCytoskeletonDataDevelopmentDiseaseDoseDrug KineticsExperimental Autoimmune EncephalomyelitisFDA approvedFluorineFunctional disorderGenesGoalsHistone DeacetylaseHumanImageImaging DeviceImaging TechniquesImmune responseImmunizationImmunomodulatorsImmunosuppressive AgentsImpairmentInflammatoryIntegral Membrane ProteinInvestigative TechniquesKnockout MiceLabelLymphocyte SubsetMagnetic Resonance ImagingMature T-LymphocyteMediatingMedical ResearchMetabolismMethodsModelingMolecular ProbesMolecular WeightMultiple SclerosisMusN-terminalNeurologicNeurologic SymptomsOralParkinson DiseasePharmaceutical PreparationsPharmacologyPharmacotherapyPlasmaPlayPositioning AttributePositron-Emission TomographyProcessProductionProlinePsoriasisRadiolabeledReceptor ActivationReceptor SignalingRegulationReportingResearchResourcesRodentRoleSignal PathwaySignal TransductionT cell therapyT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTherapeutic EffectTissuesTranslatingaxon guidancebioimagingcell motilitycopolymer 1cytokinedesigndrug discoveryexperiencefirst-in-humanhuman diseasehuman imagingimaging probein vivoin vivo imaginginhibitor/antagonistkinetic modelmanmolecular imagingmultiple sclerosis treatmentnon-invasive imagingnonhuman primatenovelpreventradiochemicalradiotracerreceptorreceptor densityrecruitresponsesmall molecule therapeuticssrc Homology Region 2 Domaintechnique developmenttooltreatment response

项目摘要

项目成果

Changning Wang的其他基金

相关文献

中文摘要
翻译
项目摘要 T细胞是淋巴细胞的一个亚群,在免疫反应中发挥着重要作用。基于T细胞的疗法有 被用于各种人类疾病,如脑瘤、阿尔茨海默病、帕金森氏病和 多发性硬化症。T细胞受体(TCR)是一种完整的膜蛋白复合体,参与 T细胞对抗原的反应而激活T细胞。TCR激活促进了许多信号级联反应, 最终通过调节细胞因子的产生、细胞的存活、增殖和 不幸的是,没有合适的非侵入性成像工具来研究这些过程 无论是在动物身上还是在人类身上。体内T细胞受体可视化技术的发展是一个关键 了解大脑中T细胞的正常功能和病理生理。此外,这些 技术将加速发现与T细胞受体相互作用的小分子疗法。 该项目旨在开发用于T细胞受体的新型PET成像探针。我们会给第一个打上- T细胞受体抑制剂AX-024与碳-11或氟-18的联合应用 通过成像T细胞受体的分布和分子作为人类T细胞受体的放射性示踪剂 啮齿动物和非人灵长类动物的药代动力学。
英文摘要
Project Summary T-cells are a subset of lymphocytes that play a large role in the immune response. T cell based therapies have been used in various human diseases, such brain tumors, Alzheimer’s disease, Parkinson’s disease and Multiple sclerosis. The T-cell receptor (TCR) is a complex of integral membrane proteins that participate in the activation of T-cells in response to an antigen. TCR activation promotes a number of signaling cascades that ultimately determine cell fate through regulating cytokine production, cell survival, proliferation, and differentiation Unfortunately, there are no suitable non-invasive imaging tools for investigating these processes in animals or in man. The development of techniques for visualizing T cell receptors in vivo represents a key step in understanding both the normal function and pathophysiology of T cells in brain. Moreover, these techniques will accelerate the discovery of small molecule therapeutics that interacts with the T cell receptors. The project is designed to develop novel PET imaging probes for T cell receptors. We will label the first-in- class T cell receptor inhibitor, AX-024, with carbon-11 or fluorine-18 and evaluate the potential of these molecules to serve as radiotracers for T cell receptors in humans by imaging their distribution and pharmacokinetics in rodents and non-human primates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BET-BD1 Selective Neuroimaging probes for Alzheimer's disease research
  • 批准号:
    10628245
  • 项目类别:
  • 资助金额:
    $244.23万
  • 财政年份:
    2023
  • 负责人:
    Changning Wang
  • 依托单位:
Investigation of sirtuin 1 expression in mice model of Alzheimer's disease over age
  • 批准号:
    10407173
  • 项目类别:
  • 资助金额:
    $32.38万
  • 财政年份:
    2022
  • 负责人:
    Changning Wang
  • 依托单位:
A new PET neuroimaging probe for sigma 1 receptor
  • 批准号:
    10272877
  • 项目类别:
  • 资助金额:
    $25.06万
  • 财政年份:
    2021
  • 负责人:
    Changning Wang
  • 依托单位:
Selective PET imaging probes targeting BD1 of N-terminal bromodomains
  • 批准号:
    10054837
  • 项目类别:
  • 资助金额:
    $24.93万
  • 财政年份:
    2020
  • 负责人:
    Changning Wang
  • 依托单位: